Rüdiger H - Search Results

1

Laser Doppler anemometry distinguishes primary Raynaud phenomenon from VWF syndrome.

Ziegler S, Gschwandtner M, Zöch C, Barth A, Minar E, Rüdiger H, Osterode W. Ziegler S, et al. Among authors: rudiger h. Microvasc Res. 2004 Nov;68(3):203-8. doi: 10.1016/j.mvr.2004.06.006. Microvasc Res. 2004. PMID: 15501239

2

Thermoregulation and rheological properties of blood in primary Raynaud's phenomenon and the vibration-induced white-finger syndrome.

Ziegler S, Zöch C, Gschwandtner M, Eckhardt G, Windberger U, Minar E, Rüdiger H, Osterode W. Ziegler S, et al. Among authors: rudiger h. Int Arch Occup Environ Health. 2005 Apr;78(3):218-22. doi: 10.1007/s00420-004-0601-7. Epub 2005 Mar 15. Int Arch Occup Environ Health. 2005. PMID: 15838713

3

Reduced cognitive abilities in lead-exposed men.

Barth A, Schaffer AW, Osterode W, Winker R, Konnaris C, Valic E, Wolf C, Rüdiger HW. Barth A, et al. Int Arch Occup Environ Health. 2002 Aug;75(6):394-8. doi: 10.1007/s00420-002-0329-1. Epub 2002 Apr 25. Int Arch Occup Environ Health. 2002. PMID: 12070635

4

Functional adrenergic receptor polymorphisms and idiopathic orthostatic intolerance.

Winker R, Barth A, Valic E, Maier R, Osterode W, Pilger A, Rüdiger HW. Winker R, et al. Among authors: rudiger hw. Int Arch Occup Environ Health. 2005 Apr;78(3):171-7. doi: 10.1007/s00420-005-0605-y. Epub 2005 Feb 18. Int Arch Occup Environ Health. 2005. PMID: 15719258 Clinical Trial.

5

Urinary 8-hydroxydeoxyguanosine and sister chromatid exchanges in patients with total hip replacements.

Pilger A, Schaffer A, Rüdiger HW, Osterode W. Pilger A, et al. J Toxicol Environ Health A. 2002 May 10;65(9):655-64. doi: 10.1080/15287390252900359. J Toxicol Environ Health A. 2002. PMID: 11996406 Clinical Trial.

6

No cognitive deficits in men formerly exposed to lead.

Winker R, Barth A, Ponocny-Seliger E, Pilger A, Osterode W, Rüdiger HW. Winker R, et al. Wien Klin Wochenschr. 2005 Nov;117(21-22):755-60. doi: 10.1007/s00508-005-0466-0. Wien Klin Wochenschr. 2005. PMID: 16416357 Clinical Trial.

7

Neurobehavioral effects of vanadium.

Barth A, Schaffer AW, Konnaris C, Blauensteiner R, Winker R, Osterode W, Rüdiger HW. Barth A, et al. Among authors: rudiger hw. J Toxicol Environ Health A. 2002 May 10;65(9):677-83. doi: 10.1080/15287390252900377. J Toxicol Environ Health A. 2002. PMID: 11996408 Clinical Trial.

8

Health consequences of an intravenous injection of metallic mercury.

Winker R, Schaffer AW, Konnaris C, Barth A, Giovanoli P, Osterode W, Rüdiger HW, Wolf C. Winker R, et al. Among authors: rudiger hw. Int Arch Occup Environ Health. 2002 Oct;75(8):581-6. doi: 10.1007/s00420-002-0363-z. Epub 2002 Jul 6. Int Arch Occup Environ Health. 2002. PMID: 12373321

9

High prevalence of chronic venous disease in hospital employees.

Ziegler S, Eckhardt G, Stöger R, Machula J, Rüdiger HW. Ziegler S, et al. Wien Klin Wochenschr. 2003 Sep 15;115(15-16):575-9. doi: 10.1007/BF03040451. Wien Klin Wochenschr. 2003. PMID: 14531170

10

Lead exposure levels and duration of exposure absence predict neurobehavioral performance.

Winker R, Ponocny-Seliger E, Rüdiger HW, Barth A. Winker R, et al. Among authors: rudiger hw. Int Arch Occup Environ Health. 2006 Feb;79(2):123-7. doi: 10.1007/s00420-005-0031-1. Epub 2005 Aug 9. Int Arch Occup Environ Health. 2006. PMID: 16088406

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

337 results

Search Page

Filters